Duncan NRI Faculty and Staff Publications
The Jan and Dan Duncan Neurological Institute is home to 37 Principal Investigators, more than 400+ scientists and 10 Core labs.
Dan and Duncan Neurological Institute also house the Gordon and Mary Cain Pediatric Neurology Research Foundation Laboratories which are focused on epilepsy research and Baylor College's of Medicine's Center for Drug Discovery which is aimed at quick identification and advancement of small molecules to clinical trials.
Since inception, more than 1700 scientific studies have been published, and more than 85 disease-causing genetic mutations have been discovered or co-discovered by our scientists. There are currently 6 active clinical trials and studies.
Submissions from 2025
Computational and Functional Prioritization Identifies Genes That Rescue Behavior and Reduce Tau Protein in Fly and Human Cell Models of Alzheimer Disease, Morgan C Stephens, Jiayang Li, Megan Mair, et al.
New Insights Into Epileptic Spasm Generation and Treatment From the TTX Animal Model, John W Swann, Carlos J Ballester-Rosado, and Chih-Hong Lee
The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease, Matthew Torre, Camila A Zanella, and Mel B Feany
Biliverdin Reductase A Is a Major Determinant of Protective NRF2 Signaling, Chirag Vasavda, Ruchita Kothari, Navneet Ammal Kaidery, et al.
From Bladder to Brain: How You Know When It’s Time To Go, Anne M J Verstegen and Kara L Marshall
Drosophila Models Uncover Substrate Channeling Effects on Phospholipids and Sphingolipids in Peroxisomal Biogenesis Disorders, Michael F Wangler, Yu-Hsin Chao, Mary Roth, et al.
ReSort Enhances Reference-Based Cell Type Deconvolution for Spatial Transcriptomics Through Regional Information Integration, Linhua Wang, Ling Wu, Guantong Qi, et al.
The cGAS/STING Pathway: Friend or Foe in Regulating Cardiomyopathy, Weiyue Wang, Yuanxu Gao, Hyun Kyoung Lee, et al.
Whole-Genome Sequencing Reveals Individual and Cohort Level Insights Into Chromosome 9p Syndromes, Yingxi Wang, Eleanor I Sams, Rachel Slaugh, et al.
The Perspectives and Experiences of Prospective Parents Declining Diagnostic Prenatal Genome Sequencing in Continuing Pregnancies With Fetal Structural Anomalies, Lisa S Weingarten, Allison Rosenbaum, Jessica de Voest, et al.
De Novo Variants in RYBP Are Associated With a Severe Neurodevelopmental Disorder and Congenital Anomalies, Monika Weisz-Hubshman, Lindsay C Burrage, Sharayu V Jangam, et al.
Microglia Sensing of Peripheral Signals That Bridge the Brain and Body, Claire E Young and Melanie A Samuel
Amniocentesis in Pregnancies at or Beyond 24 Weeks: An International Multicenter Study, Roni Zemet, Mohamad Ali Maktabi, Alexandra Tinfow, et al.
Diagnostic Yield of Exome Sequencing for Pregnancies With and Without Fetal Anomalies and for Stillbirth, Roni Zemet, Christian M Parobek, April D Adams, et al.
Refining the Utility of Late Amniocentesis in High-Risk Pregnancies, Roni Zemet, Ronald J Wapner, and Ignatia B Van den Veyver
Alzheimer’s Disease Protective Allele of Clusterin Modulates Neuronal Excitability Through Lipid-Droplet-Mediated Neuron-Glia Communication, Xiaojie Zhao, Yan Li, Siwei Zhang, et al.
Submissions from 2024
The DDHD2-STXBP1 Interaction Mediates Long-Term Memory via Generation of Saturated Free Fatty Acids, Isaac O Akefe, Saber H Saber, Benjamin Matthews, et al.
CPSF3 Inhibition Blocks Pancreatic Cancer Cell Proliferation Through Disruption of Core Histone mRNA Processing, Abdulrahman A Alahmari, Aditi H Chaubey, Venkata S Jonnakuti, et al.
TFEB Drives mTORC1 Hyperactivation and Kidney Disease in Tuberous Sclerosis Complex, Nicola Alesi, Damir Khabibullin, Dean M Rosenthal, et al.
Individualized Functional Magnetic Resonance Imaging Neuromodulation Enhances Visuospatial Perception: A Proof-of-Concept Study, Anthony Allam, Vincent Allam, Sandy Reddy, et al.
MECP2-Related Disorders While Gene-Based Therapies Are on the Horizon, Katherine Allison, Mirjana Maletic-Savatic, and Davut Pehlivan
Comparison of Four Protocols for In Vitro Differentiation of Human Embryonic Stem Cells into Trophoblast Lineages by BMP4 and Dual Inhibition of Activin/Nodal and FGF2 Signaling, Zahra Anvar, Imen Chakchouk, Momal Sharif, et al.
What’s the N? On Sample Size vs. Subject Number for Brain-Behavior Neurophysiology and Neuromodulation, Wael F Asaad and Sameer A Sheth
Author Correction: Oligodendroglial Fatty Acid Metabolism as a Central Nervous System Energy Reserve, Ebrahim Asadollahi, Andrea Trevisiol, Aiman S Saab, et al.
Oligodendroglial Fatty Acid Metabolism as a Central Nervous System Energy Reserve, Ebrahim Asadollahi, Andrea Trevisiol, Aiman S Saab, et al.